Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rivina humilis is a small tropical/subtropical plant species whose berries and other parts contain phytochemicals such as betalains, phenolics, flavonoids, and fatty acids; extracts have been studied in vitro and in animal models for antioxidant, cytotoxic, and hypoglycemic effects, but it is not an approved pharmaceutical drug. Berries accumulate betalain pigments and have been explored as natural colorants and in food applications. Preclinical studies report antioxidant activity of fruit and leaf extracts, cytotoxicity against cancer cell lines, and antidiabetic effects in streptozotocin-induced diabetic rats; mechanisms are generally attributed to antioxidant and phytochemical effects rather than a defined single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rivina humilis.